GNCP.US Gncc Capital Inc.

Basic Materials Metals & Mining USA Stocks
0.0000 USD
Close of Oct 21, 2025
Market cap
USD 6.21M
P/E
-
P/B
-
ROE
-34.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Dec 2021.

Is GNCP.US undervalued?

Graham number

The Graham number of Gncc Capital Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Gncc Capital Inc. fundamental analysis

No fundamental analysis for Gncc Capital Inc. yet.

Gncc Capital Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Gncc Capital Inc.

GNCC Capital, Inc. through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils. It sells its products through distribution channels in Colombia and throughout Latin America. The company is based in Las Vegas, Nevada.

Full company profile